{
  "abstract": "Doctors could soon be offering sodium-glucose cotransporter-2 (SGLT-2) inhibitors as a first line treatment option for all patients with diabetes, not just those with heart disease.1",
  "authors": [
    {
      "affiliations": [
        "The BMJ"
      ],
      "name": "Kate Bowie"
    }
  ],
  "title": "Type 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance “shake-up”",
  "uid": "58ee00dd-329d-5f03-a2cc-4925b8eedb40"
}